drugset / Trial / NCT00902226
Escitalopram in Patients With Social Anxiety Disorder
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the effect of escitalopram after 12 weeks of treatment in patients with Social Anxiety Disorder (SAD), to evaluate proportion of patients who respond to escitalopram during the treatment period, and to evaluate safety of escitalopram.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-12
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 5 mg | Oral |
| Subject | Escitalopram | Small molecule | 20 mg | Oral |